Xpert® BCR-ABL Ultra (Cepheid, Sunnyvale, CA, USA) is an in vitro diagnostic test for the quantification of BCR::ABL1 and ABL1 mRNA transcripts in peripheral blood specimens of diagnosed t(9;22) positive CML patients. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.